MACULAR CHANGES AND FLUORESCEIN ANGIOGRAPHIC FINDINGS AFTER REPAIR OF PROLIFERATIVE VITREORETINOPATHY

被引：18

作者：

BONNET, M

机构：

[1] Clinique Ophtalmolgique Universitaire B, UFR Lyon Nord, Hôpital de la Croix-Rousse, Lyon

来源：

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 1994年 / 14卷 / 05期

关键词：

Cystoid macular edema; Dye leakage; Fluorescein angiography; Macular pucker; Optic disc; Proliferative vitreoretinopathy; Rhegmatogenous retinal detachment; Subretinal membranes; Vitreoretinal surgery;

D O I：

10.1097/00006982-199414050-00003

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To evaluate the status of the macula after surgical treatment of proliferative vitreoretinopathy (PVR). Method: Biomicroscopic and fluorescein angiographic examination of the macula was performed in 58 eyes of 58 patients 6 to 7 months after complete gas absorption for rhegmatogenous retinal detachment complicated by PVR (grade C1 to D3). Results: Macular changes were found in 46 eyes (79.3%), and included: cystoid macular edema (30 eyes; 51.7%), epiretinal membranes distant from the macula (3 eyes; 5.1%), macular pucker (7 eyes; 12%), subretinal membranes (5 eyes; 8.6%), and subretinal pigment dispersion (5 eyes; 8.6%). In five eyes, two distinct changes were found. Optic dye leakage occurred in 4 eyes (6.8%). Conclusion: Biomicroscopic and fluorescein angiographic examination of the macula can be used to determine why eyes in which rhegmatogenous retinal detachment complicated by PVR is successfully repaired do not achieve good recovery of vision. Spontaneous improvement or disappearance of postoperative cystoid macular edema, with late improvement in visual acuity, may occur in a small number of patients.

引用

页码：404 / 410

页数：7

共 18 条

[1]

Aaberg T.M., Management of anterior and posterior proliferative vitreoretinopathy. XLV Edward Jackson Memorial Lecture, Am J Ophthalmol, 106, pp. 519-532, (1988)

[2]

Federman J.L., Schubert H.D., Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery, Ophthalmology, 95, pp. 870-876, (1988)

[3]

Fisher Y.L., Shakin J.L., Slakter J., Sorenson J.A., Shafer D.M., Perfluorocarbon gas, modified panretinal photocoagulation, and vitrectomy in the management of severe proliferative vitreoretinopathy, Arch Ophthalmol, 106, (1988)

[4]

Hanneken A.M., Michels R.G., Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy, Ophthalmology, 95, pp. 865-869, (1988)

[5]

De Juan E., McCuen B., Management of anterior vitreous traction in proliferative vitreoretinopathy, Retina, 4, pp. 258-262, (1989)

[6]

Fleury J., Bonnet M., Le c3f8 dans le traitement des cécollements de la rétine associés à une prolifération vitréorétinienne, J Fr Ophtalmol, 12, pp. 89-94, (1989)

[7]

Lewis H., Aaberg T.M., Causes of failure after repeated vitreoretinal surgery for recurrent proliferative vitreoretinopathy, Am J Ophthalmol, 111, pp. 15-19, (1991)

[8]

Lopez R., Chang S., Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy, Am J Ophthalmol, 113, pp. 424-428, (1992)

[9]

Vitrectomy with silicone oil or sulfurhexafluoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial, Arch Ophthal- Mol, 110, pp. 770-779, (1992)

[10]

Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial, Arch Ophthalmol, 110, pp. 780-792, (1992)

← 1 2 →